HIV infection is associated with increased CRP levels in men, whereas HIV/HCV coinfection is associated with decreased CRP levels in men and women.
Elevated C-reactive protein (CRP) levels are associated with increased risk for cardiovascular disease (CVD). CRP’s usefulness in predicting CVD risk in HIV-infected and HIV/HCV-coinfected patients, who may have higher rates of CVD than uninfected individuals, is not known. Because CRP is a marker of inflammation, HIV or HCV infection could affect its level. To assess this possible association, investigators compared CRP levels between 1135 HIV-infected patients enrolled in a cross-sectional study (of whom 22% were HCV-coinfected) and 251 HIV-uninfected controls.
The median CRP level was almost twice as high in HIV-monoinfected men as in control men (1.67 vs. 0.88; P<0.0001). Overall, 32% of HIV-infected men had CRP levels in the CDC/America…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)